References & Disclaimers
1. Lang, et al. Expanded Real-world Use Confirms Strong Association between Frequency of Flash Glucose Monitoring and Glucose Control. Advanced Technologies & Treatments for Diabetes Meeting. Berlin. February 20-23, 2019. Diabetes Technology & Therapeutics, Volume 21, Supplement 1, 2019.
2. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50, 1140–1147 (2007). https://doi.org/10.1007/s00125-007-0599-y.
3. Battelino, T. Diabetes Care (2019): https://doi.org/10.2337/dci19-0028
4. Bolinder, J. The Lancet (2016): https://doi.org/10.1016/S0140-6736(16)31535-5.
5. Haak, T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6.
6. Ceriello A. et al, Lancet Diabetes Endocrinol 2019 : http://dx.doi.org/10.1016/S2213-8587(18)30136-0
7. Kilpatrick, E.S., Rigby, A.S. & Atkin, S.L. Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 51, 365–371 (2008). https://doi.org/10.1007/s00125-007-0883-x
8. Campbell, Fiona M., et al. "Outcomes of Using Flash Glucose Monitoring technology by Children and young people with Type 1 Diabetes in a Single Arm Study." Pediatric Diabetes 19, no. 7 (2018): 1294-1301. https://doi.org/10.1111/pedi.12735.